Edwards Lifesciences (EW) Reports In-Line Q4 EPS, Q1 EPS Guidance Comes in Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Edwards Lifesciences (EW) PT Raised to $186 at Raymond James
February 1, 2019 7:47 AM ESTRaymond James analyst Jayson Bedford raised the price target on Edwards Lifesciences (NYSE: EW) to $186.00 (from $175.00) while maintaining a Outperform rating.
... MoreEdwards Lifesciences (EW) PT Raised to $175 at UBS
February 1, 2019 7:15 AM ESTUBS analyst Matthew Taylor raised the price target on Edwards Lifesciences (NYSE: EW) to $175.00 (from $165.00) while maintaining a Neutral rating.
... MoreEdwards Lifesciences (EW) PT Raised to $182 at RBC Capital
February 1, 2019 6:42 AM ESTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $182.00 (from $175.00) while maintaining a Outperform rating.
Novarro commented, "Revenue guidance for 1Q19, implying high-single-digit CC growth at the midpoint, adequately captures competitive dynamics in the TAVR market.... More
